Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Curiel

Showing results (181-190 of 400) with videos related to

Pageof 40
Sort By:
Plos One|February 25, 2011
Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imagingJ Michael Mathis, Shilpa Bhatia, Alok Khandelwal, et al.
Cancer Gene Therapy|June 12, 2004
Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCAMiriam Ferrer, Johan P de Winter, D C Jeroen Mastenbroek, et al.
Molecular Cancer Therapeutics|December 11, 2007
Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cellsClint Mitchell, Maragret A Park, Guo Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2008
Enhancement of cytotoxic T-lymphocyte response in aged mice by a novel treatment with recombinant AdIL-12 and wild-type adenovirus in rapid successionJian Chen, John Wang, Jun Li, et al.
The Journal of Biological Chemistry|September 19, 2006
A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expressionMd Ruhul Abid, Shu-Ching Shih, Hasan H Otu, et al.
Journal of Molecular Biology|September 13, 2008
Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsidCarmen San Martín, Joel N Glasgow, Anton Borovjagin, et al.
Cancer Gene Therapy|September 18, 2004
Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathwaysAndrea L Volk, Angel A Rivera, Grier P Page, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Transcriptional blocks limit adenoviral replication in primary ovarian tumorMeredith A Preuss, John T Lam, Minghui Wang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 6, 2007
Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertensionAnn M Reynolds, Wei Xia, Mark D Holmes, et al.
Journal of Hepatology|October 26, 2002
Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 proteinDeborah E Sullivan, Mario U Mondelli, David T Curiel, et al.
Pageof 40

Showing results (181-190 of 400) with videos related to

Sort By:
Pageof 40
Plos One|February 25, 2011
Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imagingJ Michael Mathis, Shilpa Bhatia, Alok Khandelwal, et al.
Cancer Gene Therapy|June 12, 2004
Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCAMiriam Ferrer, Johan P de Winter, D C Jeroen Mastenbroek, et al.
Molecular Cancer Therapeutics|December 11, 2007
Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cellsClint Mitchell, Maragret A Park, Guo Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2008
Enhancement of cytotoxic T-lymphocyte response in aged mice by a novel treatment with recombinant AdIL-12 and wild-type adenovirus in rapid successionJian Chen, John Wang, Jun Li, et al.
The Journal of Biological Chemistry|September 19, 2006
A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expressionMd Ruhul Abid, Shu-Ching Shih, Hasan H Otu, et al.
Journal of Molecular Biology|September 13, 2008
Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsidCarmen San Martín, Joel N Glasgow, Anton Borovjagin, et al.
Cancer Gene Therapy|September 18, 2004
Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathwaysAndrea L Volk, Angel A Rivera, Grier P Page, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Transcriptional blocks limit adenoviral replication in primary ovarian tumorMeredith A Preuss, John T Lam, Minghui Wang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 6, 2007
Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertensionAnn M Reynolds, Wei Xia, Mark D Holmes, et al.
Journal of Hepatology|October 26, 2002
Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 proteinDeborah E Sullivan, Mario U Mondelli, David T Curiel, et al.
Pageof 40